ASX Announcement October 29, 2026 Quarterly Activity Report Q1 FY27 Atomo expands and solidifies product pipeline and posts solid revenue growth • Atomo signs agreement for Generation 4 HIV product development program with 1 Innovation Scientific, adding to Atomo’s proprietary product pipeline...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
In the deck
Earlier from Atomo Diagnostics
- Atomo Signs Agreement with Innovation Scientific
- 2026 Appendix 4E and Annual Report
- Managing Director & CEO Transition
- Share Purchase Plan Results
- Response to ASX Aware Letter
Later from Atomo Diagnostics
All Atomo Diagnostics news releasesFollow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics